Inside Reproductive Health News Digest
New patient resources, clinical data, professional recognition, and investment activity set the tone for January
Elizabeth Lee’s historic run for Congress bridges reproductive medicine and federal policy.
Operator-dependent ultrasound workflows struggle to keep up with rising measurement demands
Ajay Singh examines how trust in IVF care is built and lost between appointments—and why existing systems often fail to detect erosion until patients quietly disengage.
Palm Springs bombing, LA wildfires, pushed labs to rethink monitoring, documentation, transport, and long-term storage governance
EMD Serono Deal Shakes Up Everything. New Players Emerge Where Incumbents Have Remained Stagnant
The patient journey is a nightmare. They take it out on staff. Some people are doing something about it
One Year After Lawsuits, PGT labs still on defensive. Providers Rely on Genetic Counselors
AI diagnostics, automation, and integrated platforms address variability, workflow strain, and scaling challenges in today’s fertility care systems
People Are Sick Of The Same Old Problems. Now New Challengers Begin To Crowd Out Old Players
Leaders discuss how growth, data-driven care, and new technologies are reshaping outcomes, access, and clinical workflows
Emerging research shows AMH is more than a marker of ovarian reserve, revealing an addressable therapeutic target with applications across menopause, oncofertility, and IVF stimulation.
Heavy communication loads, medication logistics, and schedule volatility are straining clinical teams beyond capacity.
The Heritage Foundation issued a white paper earlier this year urging would-be parents with fertility issues to explore non-IVF options. Clinics and industry observers say it’s not going anywhere.
The extraordinary journey of the embryologist whose work you’ll never see—but whose precision could shape your family’s future.
The two private equity firms are infusing some $1.7 billion into the company, which is expected to fuel its continued national expansion.
Meitheal executive Jinsong Liu channels deep regulatory expertise into affordable, high-quality fertility medicines and expanded access to care.
Outdated imaging and fragmented workflows slow cycle decisions and undermine patient claritY
How a physician-scientist with one of the most unexpected career paths in reproductive endocrinology hopes to leave the field better than he found it, by elevating the people who make it possible.
- CEO and C Suite 1
- Compliance 25
- Fertility Marketing 1
- IVF Lab 4
- International Care 2
- Mergers & Acquisitions 17
- Nursing Management 1
- Partnership & Recruitment 10
- Patient Relations 16
- Physician Leadership 5
- Practice Management 29
- Practice Ownership 1
- Private Equity 7
- Strategy 10
- Technological Innovation 26
- Technology 4
- Training & Education 5
- Venture Capital 5